New Group CEO is someone who understands Biocon's business synergy well: Kiran Mazumdar-Shaw

"Peter, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon Group because he has basically played a very key role in Syngene. Through Syngene, he has understood the entire Biocon business very well."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MHtrVKT
via IFTTT